Serina Net Debt from 2010 to 2026

SER Stock   1.67  0.10  5.65%   
Serina Therapeutics Net Debt yearly trend continues to be relatively stable with very little volatility. Net Debt is likely to grow to about -3.7 M this year. Net Debt is the total debt of Serina Therapeutics minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2017-12-31
Previous Quarter
-5.9 M
Current Value
-5.4 M
Quarterly Volatility
10.7 M
 
Covid
 
Interest Hikes
Check Serina Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Serina Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 165.9 K, Interest Expense of 635.1 K or Total Revenue of 47.9 K, as well as many indicators such as Price To Sales Ratio of 622, Dividend Yield of 0.0 or PTB Ratio of 54.35. Serina financial statements analysis is a perfect complement when working with Serina Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Serina Stock
Check out the analysis of Serina Therapeutics Correlation against competitors.
To learn how to invest in Serina Stock, please use our How to Invest in Serina Therapeutics guide.
Evaluating Serina Therapeutics's Net Debt across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Serina Therapeutics's fundamental strength.

Latest Serina Therapeutics' Net Debt Growth Pattern

Below is the plot of the Net Debt of Serina Therapeutics over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Serina Therapeutics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Serina Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Debt10 Years Trend
Very volatile
   Net Debt   
       Timeline  

Serina Net Debt Regression Statistics

Arithmetic Mean256,678
Geometric Mean1,423,164
Coefficient Of Variation2,493
Mean Deviation4,128,937
Median(259,000)
Standard Deviation6,398,511
Sample Variance40.9T
Range24.9M
R-Value0.07
Mean Square Error43.4T
R-Squared0.01
Significance0.79
Slope90,453
Total Sum of Squares655.1T

Serina Net Debt History

2026-3.7 M
2025-3.9 M
2024-3.4 M
2023-4.2 M
202217.5 M
202112.6 M
20205.8 M

Other Fundumenentals of Serina Therapeutics

Serina Therapeutics Net Debt component correlations

0.6-0.26-0.590.230.04-0.39-0.460.93-0.26-0.18-0.130.19-0.350.430.04-0.330.010.11-0.03
0.6-0.2-0.26-0.20.18-0.36-0.980.650.06-0.17-0.160.43-0.2-0.02-0.57-0.23-0.540.48-0.35
-0.26-0.20.11-0.36-0.610.790.1-0.560.84-0.180.89-0.820.92-0.810.470.930.46-0.740.57
-0.59-0.260.11-0.810.12-0.130.18-0.470.50.84-0.27-0.330.38-0.420.170.360.17-0.280.22
0.23-0.2-0.36-0.810.060.060.290.22-0.8-0.680.010.44-0.590.65-0.15-0.57-0.160.36-0.24
0.040.18-0.610.120.06-0.31-0.140.28-0.480.12-0.720.63-0.650.55-0.42-0.67-0.50.57-0.31
-0.39-0.360.79-0.130.06-0.310.27-0.660.43-0.510.83-0.530.59-0.480.310.60.3-0.490.38
-0.46-0.980.10.180.29-0.140.27-0.51-0.170.180.09-0.390.080.170.610.120.58-0.460.32
0.930.65-0.56-0.470.220.28-0.66-0.51-0.45-0.03-0.460.45-0.590.6-0.17-0.58-0.20.38-0.27
-0.260.060.840.5-0.8-0.480.43-0.17-0.450.250.57-0.750.93-0.910.340.920.33-0.650.52
-0.18-0.17-0.180.84-0.680.12-0.510.18-0.030.25-0.52-0.250.11-0.050.320.120.31-0.270.19
-0.13-0.160.89-0.270.01-0.720.830.09-0.460.57-0.52-0.660.76-0.650.360.760.39-0.590.4
0.190.43-0.82-0.330.440.63-0.53-0.390.45-0.75-0.25-0.66-0.880.61-0.85-0.9-0.820.98-0.74
-0.35-0.20.920.38-0.59-0.650.590.08-0.590.930.110.76-0.88-0.910.491.00.47-0.790.61
0.43-0.02-0.81-0.420.650.55-0.480.170.6-0.91-0.05-0.650.61-0.91-0.11-0.89-0.140.48-0.36
0.04-0.570.470.17-0.15-0.420.310.61-0.170.340.320.36-0.850.49-0.110.540.95-0.920.67
-0.33-0.230.930.36-0.57-0.670.60.12-0.580.920.120.76-0.91.0-0.890.540.52-0.820.63
0.01-0.540.460.17-0.16-0.50.30.58-0.20.330.310.39-0.820.47-0.140.950.52-0.860.48
0.110.48-0.74-0.280.360.57-0.49-0.460.38-0.65-0.27-0.590.98-0.790.48-0.92-0.82-0.86-0.8
-0.03-0.350.570.22-0.24-0.310.380.32-0.270.520.190.4-0.740.61-0.360.670.630.48-0.8
Click cells to compare fundamentals

About Serina Therapeutics Financial Statements

Serina Therapeutics shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Serina Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Serina Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Serina Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Debt-3.9 M-3.7 M
Net Debt To EBITDA 0.37  0.39 

Pair Trading with Serina Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Serina Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Serina Stock

  0.61OB3 OPTIBIOTIX HLTH PLCPairCorr
  0.66OSE OSE Pharma SAPairCorr

Moving against Serina Stock

  0.85EQ EquilliumPairCorr
  0.57VALN Valneva SE ADRPairCorr
  0.52GXEA Galapagos NVPairCorr
  0.378VP1 AVRICORE HEALTH INCPairCorr
  0.32DNTH Dianthus Therapeutics Buyout TrendPairCorr
The ability to find closely correlated positions to Serina Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Serina Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Serina Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Serina Therapeutics to buy it.
The correlation of Serina Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Serina Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Serina Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Serina Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Serina Stock Analysis

When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.